Day One Biopharmaceuticals: ‘Strong Buy,’ Several 2026 Milestones In Play Plus OJEMDA Growth Mar 5, 2026
Disc Medicine and Sanofi reportedly face delays for FDA national priority review vouchers Jan 15, 2026 Comments Grandbrothers/iStock Editorial via Getty Images Two drugs developed by Disc Medicine (IRON) and Sanofi...